Pharming Group N.V. Fourth quarter and full year 2023 financial results March 14, 2024 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM SPEAKERS ...

Pharming Group N.V. (NASDAQ:PHAR) Q3 2023 Earnings Conference Call October 26, 2023 7:30 AM ET Company Participants Sijmen de Vries - Chief Executive Officer Stephen Toor - Chief Commercial Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Christian Glennie - Stifel Alistair Campbell - Royal Bank of Canada Sushila Hernandez - Van Lanschot Kempen Joe Pantginis - H.C. Wainwright Hartaj Singh - Oppenheimer Simon Scholes - First Berlin Sijmen de ...

Pharming Group N.V. Third quarter 2023 financial results October 26, 2023 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM SPEAKERS ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-39822 Pharming Group N.V. (Exact Name of Registrant as Specified in Its Charter) Darwinweg 24 2333 CR Leiden The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports ...